Adverse events from pharmacopuncture treatment in Korea
نویسندگان
چکیده
منابع مشابه
History of Research on Pharmacopuncture in Korea
OBJECTIVES This study introduces the history and types of Korean pharmacopuncture and reports trends of research on Korean pharmacopuncture. METHODS Pharmacopuncture studies were searched from the first year of each search engine to 2014 by using seven domestic and foreign search databases. Selected studies were divided into the history of pharmacopuncture, kinds and features of pharmacopunct...
متن کاملPharmacopuncture in dorsopathy treatment.
This work further investigates the mechanisms of pharmacopuncture based on clinical data from patients with dorsopathy at the lumbosacral level. For the first time, pharmacopuncture was analyzed from the perspective of "classical" medicine and not using homeopathic medicine preconceptions. This confirmed the benefits of the chondro-protector Alflutop. The reduction of the vaso-reflectory reacti...
متن کاملSpontaneously Reported Hepatic Adverse Drug Events in Korea: Multicenter Study
Hepatic adverse drug reactions (ADRs) to certain drugs may differ within each country, reflecting different patterns of prescription, socioeconomic status, and culture. The purpose of this study was to assess the suspected cause of hepatic ADRs using the spontaneously reported pharmacovigilance data from Korea. A total of 9,360 spontaneously reported adverse drug events (ADEs) from nine Pharmac...
متن کاملAdverse Cardiovascular Events after a Venomous Snakebite in Korea
PURPOSE Although cardiac involvement is an infrequently recognized manifestation of venomous snakebites, little is known of the adverse cardiovascular events (ACVEs) arising as a result of snakebite in Korea. Accordingly, we studied the prevalence of ACVEs associated with venomous snakebites in Korea and compared the clinical features of patients with and without ACVEs. MATERIALS AND METHODS ...
متن کاملAdverse events of methotrexate treatment in JIA
Background Methotrexate (MTX) which has been used for 20 years in Juvenile Idiopathic Arthritis (JIA) has now become the first-choice, second-line agent for children with polyarticular course JIA. New biologic drugs are used for MTX-failing patients and have been assessed in controlled trials for effectiveness. Safety data of these drugs are slowly and selectively emerging as post-marketing dat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medicine
سال: 2021
ISSN: 0025-7974,1536-5964
DOI: 10.1097/md.0000000000025107